Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151188 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-RAD51 Homolog D (RAD51D) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1 mL
- Storage
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene.
Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity.
MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.
Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.
Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1.
Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.
Repression of mutagenesis by Rad51D-mediated homologous recombination.
Evidence for simultaneous protein interactions between human Rad51 paralogs.
Park JY, Virts EL, Jankowska A, Wiek C, Othman M, Chakraborty SC, Vance GH, Alkuraya FS, Hanenberg H, Andreassen PR
Journal of medical genetics 2016 Oct;53(10):672-680
Journal of medical genetics 2016 Oct;53(10):672-680
Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Chun J, Buechelmaier ES, Powell SN
Molecular and cellular biology 2013 Jan;33(2):387-95
Molecular and cellular biology 2013 Jan;33(2):387-95
Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity.
Huang JW, Wang Y, Dhillon KK, Calses P, Villegas E, Mitchell PS, Tewari M, Kemp CJ, Taniguchi T
Molecular cancer research : MCR 2013 Dec;11(12):1564-73
Molecular cancer research : MCR 2013 Dec;11(12):1564-73
MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.
Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T
Cancer research 2012 Aug 15;72(16):4037-46
Cancer research 2012 Aug 15;72(16):4037-46
Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.
Shammas MA, Shmookler Reis RJ, Koley H, Batchu RB, Li C, Munshi NC
Blood 2009 Mar 5;113(10):2290-7
Blood 2009 Mar 5;113(10):2290-7
Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1.
Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK, Kohno K, Mitra S, Bhakat KK
Molecular and cellular biology 2008 Dec;28(23):7066-80
Molecular and cellular biology 2008 Dec;28(23):7066-80
Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.
Wiese C, Hinz JM, Tebbs RS, Nham PB, Urbin SS, Collins DW, Thompson LH, Schild D
Nucleic acids research 2006;34(9):2833-43
Nucleic acids research 2006;34(9):2833-43
Repression of mutagenesis by Rad51D-mediated homologous recombination.
Hinz JM, Tebbs RS, Wilson PF, Nham PB, Salazar EP, Nagasawa H, Urbin SS, Bedford JS, Thompson LH
Nucleic acids research 2006;34(5):1358-68
Nucleic acids research 2006;34(5):1358-68
Evidence for simultaneous protein interactions between human Rad51 paralogs.
Schild D, Lio YC, Collins DW, Tsomondo T, Chen DJ
The Journal of biological chemistry 2000 Jun 2;275(22):16443-9
The Journal of biological chemistry 2000 Jun 2;275(22):16443-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
